Please ensure Javascript is enabled for purposes of website accessibility

By labelling stem cells or other cells with isotopes and nanoparticles, we can monitor the fate of the cells, after injecting them into small animal models. By combining this with our imaging systems, we can monitor the cells in vivo and in real time with either CT, SPECT, PET or optical methods. This provides a non invasive method to predict the efficiency of stem cell therapies or other relevant applications, including oncology.